Pattern
What the filings show, past 12 months. Nothing here rates or predicts.
- Sold in 0 of the 13 calendar months from Oct 2025 to Oct 2026.
- No sale on record before this period.
Roles from filings
Every company we track where this person has filed, newest filing first.
| Company | Title | First filing | Latest filing |
|---|---|---|---|
| Edgewise Therapeutics, Inc. (EWTX) | Director | Mar 7, 2023 | Oct 2, 2026 |
Recent filings
The last 5 days with transactions, newest first, one line per trade date. Each number links to an SEC filing.
- Oct 1, 2026, Edgewise Therapeutics, Inc.: 308 shares awarded. 1 filing: 1
- Jul 1, 2026, Edgewise Therapeutics, Inc.: 319 shares awarded. 1 filing: 1
- Apr 1, 2026, Edgewise Therapeutics, Inc.: 339 shares awarded. 1 filing: 1
- Jan 2, 2026, Edgewise Therapeutics, Inc.: 473 shares awarded. 1 filing: 1
- Nov 11, 2025, Edgewise Therapeutics, Inc.: bought 10,700 shares for $199K. 1 filing: 1
This page shows only what this person reported on SEC ownership filings. See the methodology. Spotted something wrong? Report an error.